Td Private Client Wealth LLC Biogen Inc. Transaction History

Td Private Client Wealth LLC

  • $3.58 Trillion
  • Q4 2024

A detailed history of Td Private Client Wealth LLC transactions in Biogen Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 52 shares of BIIB stock, worth $7,313. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 385 86.49%
Holding current value
$7,313
Previous $74.6 Million 89.34%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$146.47 - $191.55 $48,774 - $63,786
-333 Reduced 86.49%
52 $7.95 Million
Q3 2024

Nov 18, 2024
BUY
$189.07 - $236.8 $14,558 - $18,233
77 Added 25.0%
385 $74.6 Million
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $58,680 - $72,909
308 New
308 $71.4 Million
Q1 2024

Aug 16, 2024
SELL
$212.02 - $267.71 $593,019 - $748,784
-2,797 Reduced 89.28%
336 $72.5 Million
Q4 2023

Aug 16, 2024
SELL
$222.59 - $267.94 $65,441 - $78,774
-294 Reduced 8.58%
3,133 $811 Million
Q3 2023

Aug 16, 2024
SELL
$253.3 - $285.89 $243,421 - $274,740
-961 Reduced 21.9%
3,427 $881 Million
Q2 2023

Aug 16, 2024
SELL
$275.25 - $318.06 $79,547 - $91,919
-289 Reduced 6.18%
4,388 $1.25 Billion
Q1 2023

Aug 16, 2024
SELL
$256.56 - $292.34 $53,877 - $61,391
-210 Reduced 4.3%
4,677 $1.3 Billion
Q4 2022

Aug 16, 2024
SELL
$252.44 - $306.72 $206,495 - $250,896
-818 Reduced 14.34%
4,887 $1.35 Billion
Q3 2022

Aug 16, 2024
SELL
$194.69 - $268.46 $9,150 - $12,617
-47 Reduced 0.82%
5,705 $1.52 Billion
Q2 2022

Aug 16, 2024
BUY
$187.54 - $223.02 $135,778 - $161,466
724 Added 14.4%
5,752 $1.17 Billion
Q1 2022

Aug 16, 2024
BUY
$193.77 - $244.14 $924,864 - $1.17 Million
4,773 Added 1871.76%
5,028 $1.06 Billion
Q4 2021

Aug 16, 2024
SELL
$223.92 - $287.77 $14,106 - $18,129
-63 Reduced 19.81%
255 $61.2 Million
Q3 2021

Aug 16, 2024
BUY
$282.99 - $369.05 $2,829 - $3,690
10 Added 3.25%
318 $90 Million
Q2 2021

Aug 16, 2024
BUY
$259.0 - $414.71 $6,216 - $9,953
24 Added 7.55%
342 $118 Million
Q1 2021

Aug 16, 2024
BUY
$242.95 - $284.63 $6,802 - $7,969
28 Added 9.66%
318 $89 Million
Q4 2020

Aug 16, 2024
SELL
$236.26 - $355.63 $26,697 - $40,186
-113 Reduced 28.04%
290 $71 Million
Q3 2020

Aug 16, 2024
SELL
$264.77 - $305.71 $75,988 - $87,738
-287 Reduced 41.59%
403 $114 Million
Q2 2020

Aug 16, 2024
SELL
$258.66 - $342.55 $33,884 - $44,874
-131 Reduced 15.96%
690 $185 Million
Q1 2020

Aug 16, 2024
SELL
$268.85 - $341.04 $537,431 - $681,738
-1,999 Reduced 70.89%
821 $260 Million
Q4 2019

Aug 16, 2024
BUY
$220.06 - $304.07 $552,790 - $763,823
2,512 Added 815.58%
2,820 $837 Million

Others Institutions Holding BIIB

# of Institutions
997
Shares Held
131M
Call Options Held
1.77M
Put Options Held
2.34M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email